EUVIMEDOpdag EUVIMED
Open access

Aromatase inhibitors induce pain‐like musculoskeletal symptoms in mice: behavioural, pharmacological and pathophysiological characterization

Martial Caillaud, Sara M Herz, Eda Koseli, Jane Roberts, Esad Ulker, Dawn Jessup, Bryan McKiver, Gabriella M Silva, Isis Betancourt-Toscano, Naiara Johnson Diaz, Abrar Khan, Justin L Poklis and 3 more

British Journal of Pharmacology · 2026

DOI: 10.1111/bph.70313 ↗

At a glance

Journal article in British Journal of Pharmacology, 2026. Written by Martial Caillaud and 14 co-authors. Institution: Nantes Université, Inserm, TENS, The Enteric Nervous System in Gut and Brain Diseases, IMAD, Nantes, France. Major MEDLINE topics: Aromatase Inhibitors, Behavior, Animal, Nitriles, Pain. 42 references. The full text is freely available in PubMed Central. Funded by: NIDA NIH HHS, NCI NIH HHS, VCU School of Medicine and National Institute of Health.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background and Purpose Breast cancer, one of the most common cancers in women, primarily manifests as estrogen receptor‐positive tumours in post‐menopausal women. Aromatase inhibitors (AIs) such as letrozole are the most effective standard adjuvant endocrine therapy. However, the majority of AI‐treated patients experience musculoskeletal symptoms (AIMSS), which can lead to premature discontinuation of treatment. Well‐characterized animal models are essential to better understand the various mechanisms of AIMSS. Experimental Approach We studied the development of musculoskeletal symptoms in ovariectomized (OVX) female C57BL/6J mice treated chronically with letrozole. We performed evoked and non‐evoked behavioural measurements and assessed the extent of estrogen dependence of these changes. Electrophysiological studies and histological analyses of sciatic nerves were performed. Finally, we investigated whether letrozole was associated with the development of hyperexcitability of nociceptive neurons and an increase in pro‐inflammatory cytokines in dorsal root ganglia. Key Results Increasing doses of letrozole led to the development of musculoskeletal symptoms in evoked and non‐evoked pain‐like behavioural tests. These symptoms appear to be largely mediated by the decrease in estrogen levels. In addition, duloxetine reversed many of these behavioural changes. These symptoms were associated with a reduction in compound muscle action potentials and a decrease in sensory nerve conduction with loss of small amyelinated fibres. Furthermore, an increase in the excitability of nociceptor neurons associated with inflammation in the DRGs was induced by letrozole. Conclusion and Implications We characterized a relevant and translational mouse model of AIMSS to help exploring the cellular and molecular mechanisms of the pathophysiology of AIs toxicity.

Subjects

MeSH terms (MEDLINE)

Aromatase InhibitorsBehavior, AnimalNitrilesPainTriazolesAnimalsLetrozoleFemaleMice, Inbred C57BLMiceGanglia, SpinalDuloxetine HydrochlorideSciatic NerveOvariectomyEstrogensDisease Models, Animal

Author keywords

aromatase inhibitorsinflammationletrozolemusculoskeletal symptomspain

Substances

Aromatase InhibitorsLetrozoleNitrilesDuloxetine HydrochlorideTriazolesEstrogens

Authors and institutions

  • Nantes Université, Inserm, TENS, The Enteric Nervous System in Gut and Brain Diseases, IMAD, Nantes, France.
  • Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia, USA.
  • Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA.
  • Translational Research Initiative for Pain and Neuropathy, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, Virginia, USA.

ORCID profiles: Hamid Akbarali

Funding

  • NIDA NIH HHS
  • NCI NIH HHS
  • VCU School of Medicine and National Institute of Health
  • VCU Massey Comprehensive Cancer Center Microscopy Shared Resource

Cite

APA

Caillaud, M., Herz, S. M., Koseli, E., Roberts, J., Ulker, E., Jessup, D., McKiver, B., Silva, G. M., Betancourt-Toscano, I., Diaz, N. J., Khan, A., Poklis, J. L., Henry, N. L., Akbarali, H., & Damaj, M. I. (2026). Aromatase inhibitors induce pain‐like musculoskeletal symptoms in mice: behavioural, pharmacological and pathophysiological characterization. British Journal of Pharmacology. https://doi.org/10.1111/bph.70313

Vancouver

Caillaud M, Herz SM, Koseli E, Roberts J, Ulker E, Jessup D, et al. Aromatase inhibitors induce pain‐like musculoskeletal symptoms in mice: behavioural, pharmacological and pathophysiological characterization. British Journal of Pharmacology. 2026. doi:10.1111/bph.70313

BibTeX
@article{Caillaud2026,
  author = {Caillaud, Martial and Herz, Sara M and Koseli, Eda and Roberts, Jane and Ulker, Esad and Jessup, Dawn and McKiver, Bryan and Silva, Gabriella M and Betancourt-Toscano, Isis and Diaz, Naiara Johnson and Khan, Abrar and Poklis, Justin L and Henry, N Lynn and Akbarali, Hamid and Damaj, M Imad},
  title = {Aromatase inhibitors induce pain‐like musculoskeletal symptoms in mice: behavioural, pharmacological and pathophysiological characterization},
  journal = {British Journal of Pharmacology},
  year = {2026},
  doi = {10.1111/bph.70313}
}
Start for free →